Literature DB >> 19005150

Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.

Gulsum Tezcan1, Betil Ozhak-Baysan, Ana Alastruey-Izquierdo, Dilara Ogunc, Gozde Ongut, Sinasi Taner Yildiran, Volkan Hazar, Manuel Cuenca-Estrella, Juan Luis Rodriguez-Tudela.   

Abstract

Fusarium species are saprophytic molds which cause disseminated or localized infections in humans. Disseminated Fusarium infection can cause significant morbidity and mortality in immunocompromised patients. We present a case of disseminated fusariosis caused by Fusarium verticillioides in a patient with acute lymphoblastic leukemia and successfully treated using both liposomal amphotericin B and voriconazole.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19005150      PMCID： PMC2620848          DOI： 10.1128/JCM.01670-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans.

Authors:  E Petrikkou; J L Rodríguez-Tudela; M Cuenca-Estrella; A Gómez; A Molleja; E Mellado
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi.

Authors:  A Aberkane; M Cuenca-Estrella; A Gomez-Lopez; E Petrikkou; E Mellado; A Monzón; J L Rodriguez-Tudela
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

3.  Successful treatment of disseminated fusariosis.

Authors:  C A Rodriguez; J Luján-Zilbermann; P Woodard; M Andreansky; E E Adderson
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

4.  Phylogeny and toxigenic potential is correlated in Fusarium species as revealed by partial translation elongation factor 1 alpha gene sequences.

Authors:  Ralf Kristensen; Mona Torp; Barbara Kosiak; Arne Holst-Jensen
Journal:  Mycol Res       Date:  2005-02

5.  Fusarium infections of the skin.

Authors:  Aditya K. Gupta; Robert Baran; Richard C. Summerbell
Journal:  Curr Opin Infect Dis       Date:  2000-04       Impact factor: 4.915

Review 6.  Treating disseminated fusariosis: amphotericin B, voriconazole or both?

Authors:  Dora Y Ho; Jason D Lee; Fernando Rosso; Jose G Montoya
Journal:  Mycoses       Date:  2007-05       Impact factor: 4.377

Review 7.  Taxonomy, biology, and clinical aspects of Fusarium species.

Authors:  P E Nelson; M C Dignani; E J Anaissie
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

8.  Fusarium infection in hematopoietic stem cell transplant recipients.

Authors:  Marcio Nucci; Kieren A Marr; Flavio Queiroz-Telles; Carlos A Martins; Plinio Trabasso; Silvia Costa; Julio C Voltarelli; Arnaldo L Colombo; Alexander Imhof; Ricardo Pasquini; Angelo Maiolino; Cármino A Souza; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

9.  Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia.

Authors:  Isabelle Durand-Joly; Serge Alfandari; Zinnédine Benchikh; Marion Rodrigue; Ana Espinel-Ingroff; Benoit Catteau; Christophe Cordevant; Daniel Camus; Eduardo Dei-Cas; Francis Bauters; Laurence Delhaes; Stéphane De Botton
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 10.  Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.

Authors:  Judith A Guzman-Cottrill; Xiaotian Zheng; Ellen G Chadwick
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129
View more
  6 in total

Review 1.  Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.

Authors:  Herman A Carneiro; Jeffrey J Coleman; Alejandro Restrepo; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

2.  Combined therapy against murine-disseminated infection by Fusarium verticillioides.

Authors:  Mery Ruíz-Cendoya; Javier Pastor; Josep Guarro
Journal:  Mycopathologia       Date:  2010-09-18       Impact factor: 2.574

3.  Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases.

Authors:  Graziella Hanna Pereira; Derlene Attili de Angelis; Roosecelis Araujo Brasil; Marilena dos Anjos Martins; Dulcilena de Matos Castro e Silva; Maria Walderez Szeszs; Marcia de Souza Carvalho Melhem
Journal:  Mycopathologia       Date:  2012-10-18       Impact factor: 2.574

Review 4.  Fusarium infection: report of 26 cases and review of 97 cases from the literature.

Authors:  Maged Muhammed; Theodora Anagnostou; Athanasios Desalermos; Themistoklis K Kourkoumpetis; Herman A Carneiro; Justin Glavis-Bloom; Jeffrey J Coleman; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

5.  Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests.

Authors:  Marcela de Souza; Tetsuhiro Matsuzawa; Luzia Lyra; Ariane Fidelis Busso-Lopes; Tohru Gonoi; Angélica Zaninele Schreiber; Katsuhiko Kamei; Maria Luiza Moretti; Plínio Trabasso
Journal:  Springerplus       Date:  2014-08-30

Review 6.  Health Risks Associated with Exposure to Filamentous Fungi.

Authors:  Mary Augustina Egbuta; Mulunda Mwanza; Olubukola Oluranti Babalola
Journal:  Int J Environ Res Public Health       Date:  2017-07-04       Impact factor: 3.390
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.